Optimized decision planning to accelerate patient access to health innovations
Ascenian is a platform of experts delivering decision planning solutions in evidence generation, optimal positioning of new treatments in budget, funding and care pathways, price negotiations and continuous value demonstration planning, to ensure access to affordable innovations for patients, carers and health systems.
Over the last 5 years payer requirements increased exponentially in complexity along different types of new molecules, from cell to gene and combination treatments, and situations, from orphan status to molecules with a degree of uncertainty or complex competitor presentation.
During the same time there has also been a push for affordability and tighter management of levels of access of already launch molecules. As demands evolve, timely access to health technology innovation requires targeted decision planning support.